Priyanka Bhateja

Priyanka Bhateja's research focuses on cancer medicine, particularly head and neck cancer and lung cancer, including squamous cell carcinoma of the head and neck and non-small cell and small cell lung cancer. The work examines treatment approaches such as immunotherapy, checkpoint inhibitors, chemoradiation, and targeted drug combinations, alongside genomic markers (like MYC, KMT2D, NOTCH pathway mutations, and retinoblastoma mutations) that help predict how patients respond to treatment or their prognosis. Several studies also look at treatment side effects, such as radiation-related tissue damage and swallowing difficulties after chemoradiation.

Publication output has grown substantially over the last decade, rising from a handful of papers per year (2017-2022) to a notably higher and sustained rate of 12-26 publications annually from 2023 onward.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026